3-iodo-6-methylpyridin-2-ol | 777940-46-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-iodo-6-methylpyridin-2-ol
• 英文别名: 3-iodo-6-methylpyridin-2(1H)-one；3-iodo-6-methyl-1H-pyridin-2-one
• CAS: 777940-46-2
• 化学式: C₆H₆INO
• 分子量: 235.024
• InChiKey: SDUDNSIHVKMDIN-UHFFFAOYSA-N

物化性质

• 沸点：
  342.3±35.0 °C(Predicted)
• 密度：
  1.94±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-iodo-6-methylpyridin-2-ol 在 copper(l) iodide 、 sodium hydride 、 三氯氧磷 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 2-Chloro-3-(4-methoxyphenylsulfanyl)-6-methylpyridine
  参考文献：
  名称：

  Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands

  摘要：

  A novel series of 2-anilino-3-phenylsulfonyl-6-methylpyridines was synthesized and evaluated as corticotropin-releasing factor receptor ligands. Structure-activity relationship studies focused primarily on optimization of the 3-phenylsulfonyl group. Compounds within this series were identified which showed potent binding affinity for the CRFI receptor. Selected compounds were examined in a rat pharmacokinetic study and were found to have oral bioavailabilities ranging from 16 to 35%. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.10.097
• 作为产物：
  描述：

  2-羟基-6-甲基吡啶 在 碘 、 碳酸氢钠 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 120.0h， 生成 3-iodo-6-methylpyridin-2-ol 、 3,5-二碘-6-甲基-2(1H)-吡啶酮
  参考文献：
  名称：

  Pyridinyl derivatives for the treatment of depression

  摘要：

  本发明涉及一种新型杂环拮抗剂，其化学式为（I），以及包含所述抗拮抗剂的药物组合物，该抗剮抗剂是促肾上腺皮质激素释放因子受体（“CRF受体”）1的拮抗剂，用于治疗抑郁症、焦虑症、情感障碍、进食障碍、创伤后应激障碍、头痛、药物成瘾、炎症性疾病、药物或酒精戒断症状以及其他可以通过CRF-1受体拮抗作用来治疗的疾病。

  公开号：

  US20040209917A1

文献信息

• BICYCLIC COMPOUND
  申请人：Kamata Makoto

  公开号：US20120010247A1

  公开（公告）日：2012-01-12

  The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有ACC抑制作用的化合物，其可用作预防或治疗肥胖症、糖尿病、高血压、高脂血症、心衰、糖尿病并发症、代谢综合征、肌肉萎缩、癌症等的药物，并具有优越的疗效。本发明涉及一种由式(I)表示的化合物，其中每个符号如规范中所定义，或其盐。
• HETEROCYCLIC COMPOUND INTERMEDIATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
  申请人：Wuhan LL Science And Technology Development Co., Ltd.

  公开号：EP3889154A1

  公开（公告）日：2021-10-06

  Disclosed by the invention is a heterocyclic compound, an intermediate, and a preparation method therefor and an application thereof. Provided by the invention are a heterocyclic compound as shown in formula I, and a stereoisomer, a geometric isomer, a tautomer, a nitrogen oxide, a hydrate, a solvate, a metabolite, an ester, a pharmaceutically acceptable salt or a prodrug thereof. The heterocyclic compound hasa high P2X3 antagonistic activity, and has good selectivity, low toxicity, good metabolic stability and little taste influence.

  本发明公开了一种杂环化合物、一种中间体及其制备方法和应用。本发明提供了一种如式 I 所示的杂环化合物及其立体异构体、几何异构体、同分异构体、氧化氮、水合物、溶液、代谢物、酯、药学上可接受的盐或原药。该杂环化合物具有很高的 P2X3 拮抗活性，并且选择性好、毒性低、代谢稳定性好、味道影响小。
• [EN] HETEROCYCLIC COMPOUND INTERMEDIATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF<br/>[FR] INTERMÉDIAIRE DE COMPOSÉ HÉTÉROCYCLIQUE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 杂环类化合物、中间体、其制备方法及应用
  申请人：WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD

  公开号：WO2020135771A1

  公开（公告）日：2020-07-02

  本发明公开了一种杂环类化合物、中间体、其制备方法及应用。本发明提供了一种如式I所示的杂环类化合物、其立体异构体、几何异构体、互变异构体、氮氧化物、水合物、溶剂化物、代谢产物、酯、药学上可接受的盐或前药。该杂环类化合物具有高的P2X3拮抗活性，且具有较好的选择性，毒性较低、代谢稳定性较好、味觉影响较小。
• Radical dearomatization of arenes and heteroarenes
  作者：David Crich、Mitesh Patel

  DOI：10.1016/j.tet.2006.05.051

  日期：2006.8

  The stannane-mediated benzeneselenol-catalyzed addition of aryl iodides to a range of arenes and aromatic hetereocycles has been studied. With furan, thiophene, and several carbocyclic arenes, the addition takes place with quenching of the adduct radical by the catalytic selenol leading to moderate yields of aryl-dihydroarenes. With nitrogen heterocycles, on the other hand, it was not possible to suppress aromatization of the adduct radical and fully aromatized products were isolated. Aryl iodides bearing hydrogen bond donating groups in the ortho-position add to nitrogen heterocycles with high selectivity ortho- to the nitrogen, affording a simple one-step synthesis of potential chelating ligands. While 2-iodophenol is an excellent aryl radical source in these reactions, the homologous 1-iodo-2-naphthol fails owing to its reaction with diphenyl diselenide, which gives 1-phenylseleno-2-naphthol in high yield. (c) 2006 Elsevier Ltd. All rights reserved.
• Direct Synthesis of Heterobiaryls by Radical Addition to Pyridine: Expeditious Synthesis of Chelating Ligands
  作者：David Crich、Mitesh Patel

  DOI：10.3987/com-04-s(p)34

  日期：——

  The addition of aryl radicals to pyridine may be affected in moderate yield on exposure of aryl iodides to tributyltin hydride, AIBN, and diphenyl diselenide in hot pyridine. Mixtures of ortho-, meta-, and para-aryl substituted pyridines are typically obtained. When the iodide is ortho-substituted with a hydrogen bond donor, such as o-iodophenol, significantly improved selectivity for ortho-substituted pyridines, with potential as bidentate chelating ligands, is obtained.